Selective Serotonin Reuptake Inhibitors (SSRIs) have been causally linked to a wide variety of birth defects, including behavioral and cognitive defects, and even Autism using the FDA’s AERS database. Neuropharmacology drug expert and drug safety expert Dr. David Gortler provides an overview of the associated pharmacological effects and advises that women should stop taking SSRIs well in advance of a potential pregnancy to prevent the risk of autism and physical deformations.
Dr. David Gortler
- Expert Background:
Dr. Gortler is a Professor, research scientist and Former FDA Medical who has served as a healthcare policy advisor to a United States Presidential candidate, and who has also been invited to testify in front of the U.S. Senate as a healthcare policy expert witness, FDA expert witness and Pharmacology expert witness. He is on the editorial board of several peer-reviewed medical journals and serves as the Editor-in-Chief of Advances in Investigational Pharmacology and Therapeutic Medicine. Dr. Gortler has two decades of investigational medicine experience, and over a decade of didactic professorships at top-tiered medical schools (Yale University, Georgetown University, and George Washington University). He is an author/co-author of over 50 publications, papers, articles, reviews, clinical protocols and reports in related areas including drug pricing, FDA policy, drug safety, clinical and nonclinical pharmacology, FDA law, healthcare policy and drug development.